Silodosin in the Treatment of the Signs and Symptoms of Benign Prostatic Hyperplasia: A 9-Month, Open-label Extension Study

Benign Prostatic Hyperplasia Specific Health Status Measures in Clinical Research: How Much Change in the American Urological Association Symptom Index and the Benign Prostatic Hyperplasia Impact Index is Perceptible to Patients?

Michael J. Barry, William O. Williford, Yuchiao Chang et al. · The Journal of Urology · 1995 · 516 citations

Medicine, Pharmacotherapy, Urology +8

Phase III Multicenter Placebo-Controlled Study of Tamsulosin in Benign Prostatic Hyperplasia

Herbert Lepor · Urology · 1998 · 368 citations · Full text

Medicine, Pharmacotherapy, Urology +8

The alpha 1-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human alpha 1c subtype.

Carlos Forray, Jonathan Bard, J. M. WETZEL et al. · Molecular Pharmacology · 1994 · 349 citations

Medicine, Pharmacology, Urology +13

KMD-3213, a novel, potent, alpha 1a-adrenoceptor-selective antagonist: characterization using recombinant human alpha 1-adrenoceptors and native tissues.

Kana Shibata, Rudolf Foglar, Kuniko Horie et al. · Molecular Pharmacology · 1995 · 230 citations

Medicine, Medicinal Chemistry, Pharmacology +13

Safety and efficacy of alfuzosin 10 mg once‐daily in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: a pooled analysis of three double‐blind, placebo‐controlled studies

Claus G. Roehrborn, P. Van Kerrebroeck, J. Nørdling · British Journal of Urology · 2003 · 182 citations

Medicine, Pharmacotherapy, Urology +14